S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
Log in
NYSEARCA:IBHE

iShares iBonds 2025 Term High Yield and Income ETF Stock Forecast, Price & News

$24.98
+0.18 (+0.73 %)
(As of 03/1/2021 12:00 AM ET)
Add
Today's Range
$24.90
Now: $24.98
$25.00
50-Day Range
$24.81
MA: $24.95
$25.07
52-Week Range
$17.89
Now: $24.98
$25.08
Volume3,637 shs
Average Volume7,396 shs
Market Capitalization$22.48 million
P/E RatioN/A
Dividend Yield5.70%
BetaN/A

Basic Details

Issuer
Fund NameiShares iBonds 2025 Term High Yield and Income ETF
Tax Classification
SymbolNYSEARCA:IBHE
Inception Date1/1/2100
Fund Manager
WebN/A
PhoneN/A

Fund Focus

Asset Class
Benchmark
Category
Focus
Development Level
Region

Fund Statistics

Assets Under Management$12.58 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.00%
Other Expenses0.00%
Total Expenses0.00%
Fee Waiver0.00%
Net Expenses0.00%

Administrator, Advisor and Custodian

Administrator
Advisor
Custodian
Distributor
Transfer Agent
Trustee
Lead Market Maker

Geographic Exposure of IBHE

Currency Exposure of IBHE

Sector Exposure of IBHE

Industry Exposure of IBHE

$24.98
+0.18 (+0.73 %)
(As of 03/1/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IBHE News and Ratings via Email

Sign-up to receive the latest news and ratings for IBHE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











iShares iBonds 2025 Term High Yield and Income ETF (NYSEARCA:IBHE) Frequently Asked Questions

What stocks does MarketBeat like better than iShares iBonds 2025 Term High Yield and Income ETF?

Wall Street analysts have given iShares iBonds 2025 Term High Yield and Income ETF a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but iShares iBonds 2025 Term High Yield and Income ETF wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has iShares iBonds 2025 Term High Yield and Income ETF's stock price been impacted by Coronavirus (COVID-19)?

iShares iBonds 2025 Term High Yield and Income ETF's stock was trading at $23.21 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IBHE stock has increased by 7.6% and is now trading at $24.9806.
View which stocks have been most impacted by COVID-19
.

Is iShares iBonds 2025 Term High Yield and Income ETF a good dividend stock?

iShares iBonds 2025 Term High Yield and Income ETF pays an annual dividend of $1.42 per share and currently has a dividend yield of 5.70%. IBHE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View iShares iBonds 2025 Term High Yield and Income ETF's dividend history.

What is iShares iBonds 2025 Term High Yield and Income ETF's stock symbol?

iShares iBonds 2025 Term High Yield and Income ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IBHE."

How do I buy shares of iShares iBonds 2025 Term High Yield and Income ETF?

Shares of IBHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares iBonds 2025 Term High Yield and Income ETF's stock price today?

One share of IBHE stock can currently be purchased for approximately $24.98.

How much money does iShares iBonds 2025 Term High Yield and Income ETF make?

iShares iBonds 2025 Term High Yield and Income ETF has a market capitalization of $22.48 million.


This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.